Activity of cefiderocol and innovative β-lactam/ β-lactamase inhibitor combinations against isogenic strains of Escherichia coli expressing single and double β-lactamases under high and low permeability conditions (vol 63, 107150, 2024)

The authors regret that the printed version of the above article contained some inaccuracies in the MICs of meropenem/xeruborbactam for some recombinant isolates expressing metallo-,B-lactamases. ,B-lactamases. The main corrigendum is given in Table 1 , Table 2 , Table 3 , Table S1 , Abstract, and Results and Discussion. These errors resulted in a very few numbers of minor changes in the manuscript. Please note that these minor changes did not affect the main findings or conclusions of the study. The correct and final version follows. The authors would like to apologize for any inconvenience caused.